Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

416
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
416
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

163
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
163
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

1.3K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.3K
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

246
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
246
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

2.5K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.5K
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

92
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
92

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Setting higher standards for reports of microbial species in human cancers.

Nature cancer·2026
Same author

Robust identification of perturbed cell types in single-cell RNA-seq data.

Nature communications·2024
Same author

A consistent pattern of slide effects in Illumina DNA methylation BeadChip array data.

Epigenetics·2023
Same author

UBR5 forms ligand-dependent complexes on chromatin to regulate nuclear hormone receptor stability.

Molecular cell·2023
Same author

ResidualBind: Uncovering Sequence-Structure Preferences of RNA-Binding Proteins with Deep Neural Networks.

Methods in molecular biology (Clifton, N.J.)·2023
Same author

Discovery of antibodies and cognate surface targets for ovarian cancer by surface profiling.

Proceedings of the National Academy of Sciences of the United States of America·2022

Related Experiment Video

Updated: Sep 30, 2025

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

8.7K

Reassessing pharmacogenomic cell sensitivity with multilevel statistical models.

Matt Ploenzke1, Rafael Irizarry2

  • 1Department of Biostatistics, Harvard T.H. Chan School of Public Health, 655 Huntington Ave, Building 2, 4th Floor, Boston, MA 02115.

Biostatistics (Oxford, England)
|March 12, 2022
PubMed
Summary
This summary is machine-generated.

This study introduces a new model for analyzing pharmacogenomic data, improving the estimation of cell sensitivity to drugs. The approach enhances the reliability of drug response predictions by accounting for biological variability.

Keywords:
Bayesian analysisStatistical methods in pharmacologyStatistical modeling

More Related Videos

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
08:52

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

4.2K
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

10.7K

Related Experiment Videos

Last Updated: Sep 30, 2025

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

8.7K
Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
08:52

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

4.2K
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

10.7K

Area of Science:

  • Pharmacogenomics
  • Computational Biology
  • Cancer Research

Background:

  • Pharmacogenomic experiments systematically test drug effects on cell lines across various concentrations to link genomic markers with treatment sensitivity.
  • Quantifying drug response in cell lines is crucial but challenging due to low signal-to-noise ratios from biological and experimental variability.
  • Replicated pharmacogenomic datasets offer opportunities to increase statistical power for robust analysis.

Purpose of the Study:

  • To develop a hierarchical mixture model for estimating drug-specific cell sensitivity and classifying drug effects as broad or targeted.
  • To propose a unified approach for calculating the probability of cell susceptibility to a drug under targeted effects or effect sizes under broad effects.
  • To demonstrate the utility of the proposed model through case studies and analysis of publicly available pharmacogenomic data.

Main Methods:

  • Formulation of a hierarchical mixture model to estimate drug-specific mixture distributions for cell sensitivity.
  • Development of a unified approach to yield posterior probabilities of cell susceptibility (targeted effect) or relative effect sizes (broad effect).
  • Application of the model to assess pairwise agreements across pharmacogenomic datasets and identify drug-specific sensitivities.

Main Results:

  • The study confirms moderate pairwise agreement between many publicly available pharmacogenomic datasets.
  • Analysis identified specific cell lines (harboring EML4-ALK or NPM1-ALK gene fusions) sensitive to the drug crizotinib.
  • Significantly down-regulated cell-matrix pathways were associated with crizotinib sensitivity in these cell lines.

Conclusions:

  • The proposed hierarchical mixture model provides a robust framework for analyzing pharmacogenomic data, enhancing the estimation of drug sensitivity.
  • The unified approach allows for nuanced assessment of drug effects, distinguishing between targeted and broad mechanisms.
  • The findings highlight the potential of pharmacogenomic data integration and analysis for identifying novel drug-response relationships and therapeutic targets.